The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TLQP-21 influences both exocrine [Petrella et al, 2012] and endocrine [Stephens et al, 2012, 2017;] pancreatic function”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Stephens et al, 2012
In the citing paper
“Daily peripheral injection of TLQP-21 for days to weeks, exerts a significant biological effect both acutely and chronically in mice, rats and hamsters (e.g. [Cero et al., 2017; Fargali et al., 2014; Stephens et al., 2012; Jethwa et al., 2007; Bartolomucci et al., 2006]).”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Stephens et al., 2012
In the citing paper
“chronic peripheral infusions of TLQP-21 in obese rodents led to decreased adipocyte diameter (Possenti et al., 2012) improved hypertension (Fargali et al., 2014) and diabetes (Stephens et al., 2012)”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Stephens et al., 2012
In the citing paper
“while both these ligands induce a similar contraction of gastric fundus strips (present data) and insulin release (Stephens et al., 2012; Lo et al., 2014).”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Stephens et al., 2012
In the citing paper
“The mouse TLQP-21 sequence represents a molecular template for designing new analogues of this peptide that can serve as agonists or antagonists for C3aR1 having important implication for obesity (Possenti et al., 2012) diabetes (Stephens et al., 2012), hypertension (Fargali et al., 2014), pain (Fairbanks et al., 2014) and potentially immune functions.”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Stephens et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Self-citationKieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124 · cited 1×
“Identification of the DPP-4-catalyzed cleavage event proved to be amajor milestone in the development of methods for detecting active forms of GLP-1, and for development of new analogs that are resistant to enzymatic cleavage (Deacon et al., 1995; Kieffer et al., 1995).”
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429
Research works printed but not linked: 37
- Ahrén, 2000, Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice, Eur. J. Pharmacol., 404, 239, 10.1016/S0014-2999(00)00600-2 · DOI · Paper page
- Barragán, 1994, Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats, Am. J. Physiol., 266, E459
- Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. USA, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Bartolomucci, 2009, Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice, Genes Nutr, 4, 49, 10.1007/s12263-009-0110-0 · DOI
- Cocco, 2007, VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets, J. Histochem. Cytochem., 55, 619, 10.1369/jhc.6A7040.2007 · doi:10.1369/jhc.6a7040.2007
- Cornu, 2009, Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop, Diabetes, 58, 1816, 10.2337/db09-0063 · DOI
- Cornu, 2010, Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression, J. Biol. Chem., 285, 10538, 10.1074/jbc.M109.091116 · DOI
- Efanova, 1998, Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration, J. Biol. Chem., 273, 33501, 10.1074/jbc.273.50.33501 · DOI · Paper page
- Ferri, 1992, A novel neuroendocrine gene product: selective VGF8a gene expression and immuno-localisation of the VGF protein in endocrine and neuronal populations, Brain Res. Mol. Brain Res., 13, 139, 10.1016/0169-328X(92)90053-E · DOI
- Finegood, 2001, Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death, Diabetes, 50, 1021, 10.2337/diabetes.50.5.1021 · DOI · Paper page
- Garcia, 2005, A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway, J. Biol. Chem., 280, 41595, 10.1074/jbc.M509122200 · DOI
- Greig, 1999, Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations, Diabetologia, 42, 45, 10.1007/s001250051111 · DOI · Paper page
- Hahm, 1999, Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance, Neuron, 23, 537, 10.1016/S0896-6273(00)80806-5 · DOI · Paper page
- Hatanaka, 1994, The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level, J. Pharmacol. Toxicol. Methods, 31, 161, 10.1016/1056-8719(94)90079-5 · DOI
- Hui, 2002, The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects, Eur. J. Endocrinol., 146, 863, 10.1530/eje.0.1460863 · DOI
- Hunsberger, 2007, Antidepressant actions of the exercise-regulated gene VGF, Nat. Med., 13, 1476, 10.1038/nm1669 · DOI · Paper page
- Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · DOI · Paper page
- Jhala, 2003, cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2, Genes Dev., 17, 1575, 10.1101/gad.1097103 · DOI · Paper page
- Levi, 2004, Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor, Cell. Mol. Neurobiol., 24, 517, 10.1023/B:CEMN.0000023627.79947.22 · DOI
- Maedler, 2005, Sulfonylurea induced beta-cell apoptosis in cultured human islets, J. Clin. Endocrinol. Metab., 90, 501, 10.1210/jc.2004-0699 · DOI · Paper page
- Ovalle, 2002, Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus, Diabetes Obes. Metab., 4, 56, 10.1046/j.1463-1326.2002.00183.x · DOI
- Possenti, 1999, Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells, Endocrinology, 140, 3727, 10.1210/endo.140.8.6920 · doi:10.1210/endo.140.8.6920
- Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · DOI · Paper page
- Reimer, 2002, Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice, Eur. J. Endocrinol., 146, 717, 10.1530/eje.0.1460717 · DOI · Paper page
- Salton, 1991, Nucleotide sequence and regulatory studies of VGF, a nervous system-specific mRNA that is rapidly and relatively selectively induced by nerve growth factor, J. Neurochem., 57, 991, 10.1111/j.1471-4159.1991.tb08248.x · doi:10.1111/j.1471-4159.1991.tb08248.x
- Salton, 1991, Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells, Mol. Cell. Biol., 11, 2335, 10.1128/MCB.11.5.2335 · doi:10.1128/mcb.11.5.2335
- Schisler, 2005, The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells, Proc. Natl. Acad. Sci. USA, 102, 7297, 10.1073/pnas.0502168102 · DOI · Paper page
- Schisler, 2008, Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1, Mol. Cell. Biol., 28, 3465, 10.1128/MCB.01791-07 · DOI
- Severini, 2009, In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions, Br. J. Pharmacol., 157, 984, 10.1111/j.1476-5381.2009.00192.x · DOI · Paper page
- Stoffers, 2000, Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas, Diabetes, 49, 741, 10.2337/diabetes.49.5.741 · DOI · Paper page
- Szayna, 2000, Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats, Endocrinology, 141, 1936, 10.1210/endo.141.6.7490 · doi:10.1210/endo.141.6.7490 · Paper page
- Trani, 2002, Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor, J. Neurochem., 81, 565, 10.1046/j.1471-4159.2002.00842.x · DOI
- van den Pol, 1989, Hypothalamic expression of a novel gene product, VGF: immunocytochemical analysis, J. Neurosci., 9, 4122, 10.1523/JNEUROSCI.09-12-04122.1989 · DOI
- Wang, 2004, Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells, Diabetologia, 47, 478, 10.1007/s00125-004-1327-5 · DOI · Paper page
- Watson, 2005, VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity, Endocrinology, 146, 5151, 10.1210/en.2005-0588 · DOI
- Watson, 2009, Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure, BMC Physiol., 9, 19, 10.1186/1472-6793-9-19 · DOI
- Xu, 1999, Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats, Diabetes, 48, 2270, 10.2337/diabetes.48.12.2270 · DOI · Paper page
Cited by
Inactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
Cero, C., Vostrikov, V. V., Verardi, R., Severini, C., Gopinath, T., Braun, P. D., Sassano, M. F., Gurney, A., Roth, B. L., Vulchanova, L., et al. (2014) · Structure · doi:10.1016/j.str.2014.10.001 · Cited by 71
Wu, R. T., Cao, L., Mattson, E., Witwer, K. W., Cao, J., Zeng, H., He, X., Combs, G. F., & Cheng, W. (2017) · Aging Cell · doi:10.1111/acel.12529 · Cited by 37
“Area under curve analyses (Stephens et al., 2012) and plasma Se concentrations (Holmstrom et al., 2012) were determined as previously described.”
MethodClearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Metadata
- Authors
- Stephens, S. B., Schisler, J. C., Hohmeier, H. E., An, J., Sun, A. Y., Pitt, G. S., & Newgard, C. B.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 16
- Issue
- 1
- Pages
- 33-43
- ISSN
- 1550-4131
- Cited by
- 89
- References
- 6
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 381 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function. https://app.cochat.ai/papers/10.1016/j.cmet.2012.05.011
- The paper
- Stephens, S. B., Schisler, J. C., Hohmeier, H. E., An, J., Sun, A. Y., Pitt, G. S., & Newgard, C. B. (2012). A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function. Cell Metabolism. https://doi.org/10.1016/j.cmet.2012.05.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.